Key facts
- This page summarizes Barry Canton's Form 4 filing for Ginkgo Bioworks Holdings, Inc. (DNA).
- 10 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 21 Oct 2026, 16:06.
Barry Canton - 16 Oct 2026 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- DNA
- Reported as of
- 16 Oct 2026
- Net transaction value
- -$417,608
- SEC form
- 4
- Accepted by SEC
- 21 Oct 2026, 16:06:40 UTC
- Prior SEC filing
- 30 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Karen Tepichin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Barry Canton filed Form 4 for Ginkgo Bioworks Holdings, Inc. (DNA) on 21 Oct 2026.
Change
- Previous filing in this sequence was filed on 30 Jul 2026.
- Current net transaction value: -$417,608.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001882756
Primary reporting owner
Canton Barry
- Relationship
- 10%+ Owner
- Address
- C/O GINKGO BIOWORKS HOLDINGS, 27 DRYDOCK AVENUE, BOSTON
- Signature
- /s/ Karen Tepichin, Attorney-in-Fact
- Signature date
- 21 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNA
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +26,802
- Change %
- +7.9%
- Price
- Shares after
- 365,370
- Date
- 16 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
DNA
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +9,762
- Change %
- +2.7%
- Price
- Shares after
- 375,132
- Date
- 16 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
DNA
transaction
Class A Common Stock
Sale
- Transaction value
- -$190,719
- Shares
- -18,803
- Change %
- -5%
- Price
- $10.14
- Shares after
- 356,329
- Date
- 19 Oct 2026
- Ownership
- Direct
- Footnotes
- F2
DNA
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +29,279
- Change %
- +6.7%
- Price
- Shares after
- 465,701
- Date
- 16 Oct 2026
- Ownership
- By Spouse
- Footnotes
- F1
DNA
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +10,619
- Change %
- +2.3%
- Price
- Shares after
- 476,320
- Date
- 16 Oct 2026
- Ownership
- By Spouse
- Footnotes
- F1
DNA
transaction
Class A Common Stock
Sale
- Transaction value
- -$226,889
- Shares
- -22,369
- Change %
- -4.7%
- Price
- $10.14
- Shares after
- 453,951
- Date
- 19 Oct 2026
- Ownership
- By Spouse
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DNA
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -26,802
- Change %
- -75%
- Price
- Shares after
- 8,934
- Date
- 16 Oct 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 26,802
- Exercise price
- Footnotes
- F1, F3
DNA
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -9,762
- Change %
- -8.3%
- Price
- Shares after
- 107,373
- Date
- 16 Oct 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 9,762
- Exercise price
- Footnotes
- F1, F4
DNA
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -29,279
- Change %
- -75%
- Price
- Shares after
- 9,759
- Date
- 16 Oct 2026
- Ownership
- By Spouse
- Underlying class
- Class A Common Stock
- Underlying amount
- 29,279
- Exercise price
- Footnotes
- F1, F3
DNA
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -10,619
- Change %
- -8.3%
- Price
- Shares after
- 116,804
- Date
- 16 Oct 2026
- Ownership
- By Spouse
- Underlying class
- Class A Common Stock
- Underlying amount
- 10,619
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Footnote F2
Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
Footnote F3
The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% vested on October 16, 2026 and 25% will vest on January 21, 2027.
Footnote F4
The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters.